Liposomal cisplatin in cancer patients with renal failure.

Trial Profile

Liposomal cisplatin in cancer patients with renal failure.

Completed
Phase of Trial: Phase II

Latest Information Update: 11 Sep 2012

At a glance

  • Drugs Cisplatin (Primary) ; Fluorouracil; Folinic acid; Gemcitabine; Paclitaxel
  • Indications Bladder cancer; Gastrointestinal cancer; Non-small cell lung cancer
  • Focus Therapeutic Use
  • Sponsors Regulon
  • Most Recent Events

    • 11 Sep 2012 New trial record
    • 15 Aug 2012 Results from this trial to be published in the Journal of Drug Delivery & Therapeutics, according to a Regulon media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top